Study of incidence and risk factors of retinopathy of prematurity in tertiary care centre
Kerala Journal of Ophthalmology · 2016
DOI: 10.4103/0976-6677.193879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kerala Journal of Ophthalmology, 2016. Verfasst von Saravanan Jothi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Purpose
Retinopathy of prematurity (ROP) is a preventable cause of childhood blindness. Identification of risk factors is essential for its early detection and management.
Aim
The aim of this study was to analyze the incidence and risk factors of Retinopathy of Prematurity in preterm babies admitted in neonatal care unit over the period of one year. Materials and Methods: A clinical retrospective study was done among 259 preterm babies referred to our department from October 2014 to September 2015 for screening of ROP. Fundus examination with indirect ophthalmoscope (IDO) was done. Babies with manifestation of ROP were followed-up for progression and managed appropriately.
Results
One hundred and forty-two (54.8%) babies were found to have ROP at various stages. In very low birth weight (VLBW) babies (
Zitieren
APA
Jothi, S., Mangalanathan, H., Kamatchi, M., Viswanathan, V., & Karicheri, S. (2016). Study of incidence and risk factors of retinopathy of prematurity in tertiary care centre. Kerala Journal of Ophthalmology. https://doi.org/10.4103/0976-6677.193879
Vancouver
Jothi S, Mangalanathan H, Kamatchi M, Viswanathan V, Karicheri S. Study of incidence and risk factors of retinopathy of prematurity in tertiary care centre. Kerala Journal of Ophthalmology. 2016. doi:10.4103/0976-6677.193879
BibTeX
@article{Jothi2016,
author = {Jothi, Saravanan and Mangalanathan, Hemanandini and Kamatchi, Malligai and Viswanathan, Vinetha and Karicheri, Swetha},
title = {Study of incidence and risk factors of retinopathy of prematurity in tertiary care centre},
journal = {Kerala Journal of Ophthalmology},
year = {2016},
doi = {10.4103/0976-6677.193879}
}
EUVIMED